Imaging of coronary atherosclerosis and vulnerable plaque by Velzen, Joëlla Esther van
 Summary and Conclusion

269
Su
m
m
ar
y 
an
d
 C
o
nc
lu
si
o
n 
SUMMARY AND CONCLUSION
Coronary atherosclerosis remains one of the leading causes of morbidity and mortality 
in the modern western world. It has been established that the majority of acute coro-
nary events (>70%) are caused by plaque rupture followed by thrombus formation. The 
most common substrate for thrombus formation has been proposed to be the thin cap 
fi broatheroma; a plaque with a large necrotic core and thin fi brous cap (<65 μm thick) 
infi ltrated by macrophages and lymphocytes. Notably, a considerable number of patients 
who present with an acute coronary event due to rupture or erosion of an atherosclerotic 
plaque do not experience any prior symptoms. This observation emphasizes the need 
to improve the early detection of atherosclerosis. Traditionally, imaging of the coronary 
arteries has focused on the assessment of the coronary lumen and the presence of 
severe stenosis by means of invasive coronary angiography. However, invasive coronary 
angiography only allows the assessment of the lumen and is less suited to evaluate the 
presence of non-obstructive atherosclerosis, including the presence of (potentially high-
risk) plaques. As a result, there is an emerging need for imaging modalities that can 
identify atherosclerotic lesions with high-risk features indicating increased vulnerability. 
In this regard, non-invasive techniques may be valuable, as they may identify high-risk 
patients at a relatively early stage before an adverse events occurs and may provide the 
opportunity for novel treatment strategies. Accordingly, this thesis focuses on the perfor-
mance and clinical impact of imaging modalities for the evaluation of atherosclerosis and 
detection of vulnerable plaques in the coronary arteries. 
The general introduction in Chapter 1 of this thesis provides a description of the 
rationale to improve early detection of atherosclerosis and vulnerable plaque before the 
occurrence of an adverse cardiac event. An overview of the currently available invasive 
and non-invasive modalities for the imaging of coronary atherosclerosis and vulnerable 
plaque is provided, describing the individual strengths and accuracies of each imaging 
modality. Lastly, the outline of the current thesis is presented.
Part 1
Part 1 describes the current advances of computed tomography angiography (CTA) in the 
characterization of coronary atherosclerosis and vulnerable plaque. CTA is a rapidly evolv-
ing imaging tool that allows for the non-invasive visualization of coronary atherosclerosis. 
The temporal and spatial resolution have improved with each new scanner generation, 
resulting in superior image quality and diagnostic accuracy for the detection of coronary 
stenosis. CTA is not only able to identify stenosis, but also has the potential to provide 
information on lesion morphology and plaque composition. Further improvement in 
plaque characterization, however, is needed before accurate evaluation of plaque compo-
sition and subsequent identifi cation of patients at higher risk of events can be achieved.
In Chapter 2, the performance of the novel volumetric CTA system regarding plaque 
characterization was evaluated. This scanner is equipped with 320-detector rows and can 
potentially improve the ability and reliability of CTA to characterize plaque composition 
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in the coronary arteries. In this chapter, plaque observations on 320-row CTA were com-
pared to plaque composition on virtual histology intravascular ultrasound (VH IVUS) in 65 
patients. On CTA, three plaque types were identifi ed: non-calcifi ed, mixed and calcifi ed. 
On VH IVUS, plaque composition (% fi brotic, fi bro-fatty, necrotic core, dense calcium) and 
presence of thin cap fi broatheroma (more high risk) were evaluated. Plaque observations 
on 320-row CTA show good agreement to relative plaque composition on VH IVUS. More-
over, mixed plaques on 320-row CTA parallel the more vulnerable plaque on VH IVUS.
In Chapter 3, the relation between plaque composition and degree of stenosis was 
evaluated by CTA and VH IVUS. In 78 patients CTA was performed (identifying 3 plaque 
types; non-calcifi ed, calcifi ed, mixed) followed by invasive coronary angiography and VH 
IVUS. VH IVUS evaluated plaque composition (% fi brotic, fi bro-fatty, necrotic core, dense 
calcium) and plaques were visually classifi ed. For each plaque, degree of stenosis was 
evaluated by quantitative coronary angiography. Interestingly, plaque types on CTA were 
equally distributed among signifi cant (≥ 50%) and non-signifi cant stenoses. In addition, 
VH IVUS observed no differences in % fi brotic, fi bro-fatty, dense calcium and necrotic 
core. Importantly, thin cap fi broatheroma (the more vulnerable plaque) was distributed 
equally between signifi cant and non-signifi cant stenosis (p=0.18). This study indicates 
that there is no evident relation between the degree of stenosis and plaque composition 
or vulnerability.
Chapter 4 assessed the difference in location between site of greatest vulnerability and 
site of most severe narrowing with invasive VH IVUS. In 92 patients, the site of greatest 
vulnerability on VH IVUS was defi ned as the cross-section with the largest necrotic core 
area per vessel, the maximum necrotic core site and the site of most severe narrowing was 
defi ned the minimum lumen area site. The distance from both the maximum necrotic core 
site and minimum lumen area site to the origin of the coronary artery was evaluated with 
a dedicated software tool in the longitudinal IVUS view. In addition, the presence of a thin 
cap fi broatheroma was assessed. Interestingly, there was a substantial difference between 
the minimum lumen area site and maximum necrotic core site (10.8 ±20.6 mm). Moreover, 
the maximum necrotic core site was located at the minimum lumen area site in only 7 
vessels (5%). In 92 vessels (66%) the maximum necrotic core site was located proximally to 
the minimum lumen area site and in 40 vessels (29%) distally to the minimum lumen area 
site. The present fi ndings demonstrate that the site of greatest vulnerability is rarely at 
the site of most severe narrowing. Moreover, the site of greatest vulnerability is frequently 
located proximal from the site of most severe narrowing.
In Chapter 5, the aim of the study was to systematically investigate the accuracy of 
CTA for detecting signifi cant stenosis (using conventional coronary angiography as the 
reference standard) versus detecting the presence of atherosclerosis (using IVUS as refer-
ence of standard). CTA correctly ruled out signifi cant stenosis in 53 of 53 (100%) patients. 
However, 9 patients (19%) were incorrectly diagnosed as having signifi cant lesions on CTA 
resulting in sensitivity, specifi city, positive and negative predictive values of 100%, 85%, 
81% and 100%. Interestingly, CTA correctly ruled out the presence of atherosclerosis in 
7 patients (100%) and correctly identifi ed the presence of atherosclerosis in 93 patients 
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(100%). No patients were incorrectly classifi ed, resulting in sensitivity, specifi city, positive 
and negative predictive values of 100%. These fi ndings confi rm that the diagnostic per-
formance of CTA is superior in the evaluation of presence or absence of clinically relevant 
atherosclerosis as compared to the evaluation of signifi cant stenosis.
More accurate lesion assessment may be feasible with CTA as compared to invasive 
coronary angiography. Accordingly, lesion length assessment was compared between 
invasive coronary angiography and CTA in patients referred for CTA who underwent sub-
sequent percutaneous coronary intervention in Chapter 6. In 89 patients, lesion length 
was measured from the proximal to the distal shoulder of the plaque on CTA. Quantitative 
coronary angiography was performed to analyze lesion length. Interestingly, lesion length 
on CTA was signifi cantly longer than on quantitative coronary angiography (difference 8.8 
±6.7mm, p<0.001). Moreover, lesion length visualized on CTA was also signifi cantly longer 
than mean stent length (CTA lesion length-stent length was 4.2 ±8.7 mm, p<0.001). The 
study concludes that CTA provides more accurate lesion length assessment than invasive 
coronary angiography and may facilitate improved guidance of percutaneous treatment 
of coronary lesions.
Several previous studies have identifi ed specifi c plaque characteristics which are fre-
quently observed with CTA in patients presenting with acute coronary syndrome. Among 
these characteristics, a spotty pattern of calcifi cations and positive remodeling have been 
related to the presence of acute coronary syndrome. Chapter 7 systematically compared 
calcifi cation patterns in plaques visualized on CTA with vulnerable plaque characteris-
tics on VH IVUS in 108 patients. Interestingly, plaques with small spotty calcifi cations 
on CTA were related to more vulnerable plaque characteristics on VH IVUS. Chapter 8 
further addressed this issue by assessing the association between positive remodeling on 
quantitative CTA and vulnerable plaque characteristics on VH IVUS. On CTA, the remodel-
ing index was determined for each lesion using a novel dedicated quantitative analysis 
strategy. Notably, the study confi rms that lesions with positive remodeling on CTA were 
associated with a higher percentage necrotic core and a higher prevalence of thin cap 
fi broatheroma. Accordingly, evaluation of spotty calcifi cations and remodeling on CTA 
may be valuable markers for plaque vulnerability.
Part 2
In part 2 of this thesis, the relation between characterization of atherosclerosis on CTA 
and the effect on clinical management was evaluated in more detail. Chapter 9 provides 
an overview regarding the evolving role of coronary CTA (including coronary calcium 
scoring) in the diagnosis of patients with acute chest pain which constitute a common 
and important diagnostic challenge. As a result of rapid developments in coronary CTA 
technology, high diagnostic accuracies for detecting coronary stenosis are obtained. 
Additionally, CTA is an excellent modality in patients whose symptoms suggest other 
non-coronary causes of acute chest pain such as aortic aneurysms, aortic dissection, or 
pulmonary embolism. However, although CT shows great potential in evaluating patients 
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with acute chest pain, more randomized clinical trials are needed to determine the value 
of this technique in this challenging patient population. 
Chapter 10 addresses effective strategies to reduce radiation dose with CTA. On the 
one hand, a conservative approach regarding radiation dose may result in a high level of 
image noise and therefore in non-diagnostic images. On the other hand, higher radia-
tion exposure may put patients at unnecessary risk of radiation damage. Thus, effective 
strategies to reduce radiation dose, such as prospective triggering, heart rate control, 
ECG-modulation of the tube current, and use of tube voltage below 100 kV, will need to 
be applied in the clinical setting.
Chapter 11 evaluated the diagnostic accuracy of the novel 320-row CTA in the evalu-
ation of signifi cant coronary artery stenosis in 64 patients, compared with invasive coro-
nary angiography as the standard of reference. High sensitivity, specifi city, and positive 
and negative predictive values to detect ≥ 50% luminal narrowing on a patient basis of 
100%, 88%, 92%, and 100%, respectively, were demonstrated. The study concludes that 
320-row CTA allows for accurate non-invasive assessment of signifi cant coronary artery 
disease (CAD). Chapter 12 further addressed the diagnostic accuracy of 320-row CTA, 
specifi cally in patients presenting with acute chest pain and examined the relation to 
outcome during follow-up. Among the 106 patients presenting with chest pain, 22% had 
a normal CTA, 18% had non-signifi cant CAD on CTA and 55% had signifi cant CAD on CTA 
(5% had uninterpretable CTA). Sensitivity, specifi city, and positive and negative predictive 
values to detect signifi cant CAD on CTA were 100%, 87%, 93%, and 100%, respectively. 
The study concludes that in patients presenting with acute chest pain, an excellent clinical 
performance for the non-invasive assessment of signifi cant CAD is demonstrated using 
320-row CTA. Importantly, normal or non-signifi cant CAD on CTA predicted a low rate of 
adverse cardiovascular events and favorable outcome during follow-up.
The aim of Chapter 13 was to evaluate the relationship between the calcium score 
and the degree and character of atherosclerosis in patients suspected of acute coronary 
syndrome versus patients with stable CAD. Overall, 112 patients were studied; 53 with 
acute coronary syndrome and 59 with stable CAD. CTA and VH IVUS were performed 
to evaluate plaque characteristics. Interestingly, if the calcium score was zero, patients 
with acute coronary syndrome had a higher mean number of plaques and non-calcifi ed 
plaques on CTA than patients with stable CAD. In zero calcium score, VH IVUS demon-
strated that patients with acute coronary syndrome had a larger amount of necrotic core 
area and higher mean number of thin cap fi broatheroma than stable CAD. Thus, even 
in the presence of a zero calcium score, patients with acute coronary syndrome have 
increased plaque burden as well as increased vulnerability as compared to stable CAD. 
The aim of Chapter 14 was to determine the relation between CTA fi ndings and the 
rate of subsequent invasive coronary angiography and revascularization. A total of 1042 
CTA investigations were available for analysis. In patients with signifi cant CAD on CTA, 
subsequent invasive coronary angiography rate was 64%. In patients with non-signifi cant 
CAD on CTA, subsequent invasive coronary angiography rate was 12% and in patients with 
normal CTA results, subsequent invasive coronary angiography rate was 3.6% (p<0.001). 
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Of patients with signifi cant CAD on CTA, revascularization rate was 36%, as compared to a 
revascularization rate of 0.3% in patients with non-signifi cant CAD on CTA and no revas-
cularizations in patients with a normal CTA results (p<0.001). This chapter concludes that 
CTA results are strong and independent determinants of subsequent invasive coronary 
angiography and revascularization. 
Previous studies have shown that the presence of stenosis alone on CTA only has a 
limited value for predicting the presence of ischemia on myocardial perfusion imaging. In 
the last chapter (Chapter 15), different variables of atherosclerosis on CTA were related 
to ischemia on myocardial perfusion imaging to determine the different predictors of 
ischemia in 514 patients. On a patient basis, multivariate analysis showed that the degree 
of stenosis (presence of ≥70% stenosis, OR 3.5), plaque extent and composition (mixed 
plaques ≥3, OR 1.7 and calcifi ed plaques ≥3, OR 2.0) and location (atherosclerotic disease 
in left main coronary artery and/or proximal left anterior descending coronary artery, 
OR 1.6) were independent predictors for ischemia on myocardial perfusion imaging. In 
addition, CTA variables of atherosclerosis such as plaque extent, composition and loca-
tion had signifi cant incremental value for the prediction of ischemia over the presence of 
≥70% stenosis. Thus, in addition to the degree of stenosis, CTA variables of atherosclerosis 
describing plaque extent, composition and location are predictive of the presence of 
ischemia on myocardial perfusion imaging. 
Conclusions
During the past few years CTA has rapidly developed into a versatile non-invasive imaging 
modality. While imaging of the coronary arteries to determine or rule out the presence 
of stenosis will remain one of the main indications, additional information on plaque 
severity and composition can be obtained. The improvements in technology (faster 
gantry rotation times, an increasing number of detectors, volumetric image acquisition) 
and consequential improvement in image quality have resulted in advances in the charac-
terization of coronary atherosclerosis and vulnerable plaque. Interestingly, the diagnostic 
performance of CTA was superior in the evaluation of presence or absence of clinically 
relevant atherosclerosis as compared to the evaluation of signifi cant stenosis. Regard-
ing plaque observations with the novel 320-row CTA scanner, the results showed good 
agreement to relative plaque composition on invasive VH IVUS. Moreover, mixed plaques 
on 320-row CTA paralleled the more vulnerable plaque on VH IVUS. In addition, lesions 
with spotty calcifi cations and positive remodeling on CTA were associated with a higher 
percentage necrotic core and a higher prevalence of vulnerable plaques. Accordingly, 
evaluation of spotty calcifi cations and remodeling on CTA may be valuable markers for 
plaque vulnerability. 
The relation between characterization of atherosclerosis on CTA and its effect on clini-
cal management was also evaluated. As a result of rapid developments in coronary CTA 
technology, high diagnostic accuracies of 320-row CTA for detecting coronary stenosis 
were obtained in patients with stable chest pain complaints as well as in patients pre-
senting with acute chest pain. In addition, although a zero calcium score has important 
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prognostic value, patients with acute coronary syndrome and zero calcium had increased 
plaque burden as well as increased vulnerability as compared to patients with stable 
chest pain. Accordingly, absence of coronary calcifi cation did not exclude the presence 
of clinically relevant and potentially vulnerable atherosclerotic plaque burden in patients 
with acute coronary syndrome. Lastly, in addition to the degree of stenosis, CTA variables 
of atherosclerosis describing plaque extent, composition and location were predictive of 
the presence of ischemia on myocardial perfusion imaging. Possibly, these results may 
allow a more refi ned and individualized assessment of patients undergoing CTA imaging 
and provide the basis for the development of an algorithm to improve identifi cation of 
patients requiring more aggressive therapy or intervention.
